Colgate-Palmolive Company

CL · NYSE · USD

Analysis

Last 4 earnings calls · through Q2 FY2026

Across four calls Colgate went from a category slowdown and a cost scare to reaccelerating volumes and a raised outlook. The whole story now turns on whether pricing and self-funding keep outrunning commodity costs. How much of this year's cost inflation has Colgate already priced in?

  • Volume growth came back, and emerging markets did the work.

    Q3 FY2025 was carried by price, with volumes flat. By Q2 FY2026 sales grew in four of five divisions, led by India, Brazil, Mexico and China, which management calls 'accretive' and now invests behind deliberately. How much of Colgate's growth now comes from emerging markets?

  • Cost inflation forced a guidance cut, then margin came straight back.

    In Q1 FY2026 management cut its gross margin outlook as oil spiked, flagging $300 million of extra raw material and freight costs. One quarter later margin rose and the guide moved back to roughly flat, on pricing, mix and productivity. How much of Colgate's margin recovery came from pricing rather than cost cuts?

  • The US is the one division still going backwards.

    Management said it was 'not satisfied': May category volumes fell, retailers cut inventory, and shipments ran below demand. Everywhere else improved, so these US price gaps it must close without a discount war are what cap the company.

Bullish
  • Emerging market brand strength
    The bull case is that Colgate's brands and emerging market scale let it take share and raise prices even where category growth is weak.
  • Hill's premium pet nutrition
    Hill's science-led pet nutrition keeps growing faster than a flat category, giving the company a premium business that carries higher margins.
  • Cash funds brand investment
    Cash generation is strong enough to fund higher advertising, absorb commodity inflation and still return most free cash flow to shareholders.
Bearish
  • U.S. share and shipment losses
    The bear case is that North America has repeatedly missed the recovery management expected, with share losses and retailer destocking cutting shipments.
  • Slower category growth
    Category growth has settled at roughly half its historical rate, which invites more couponing and price competition across the company's core categories.
  • Rising input and tariff costs
    Raw material, logistics and tariff costs keep rising, so gross margin gains depend on pricing and productivity that may not repeat.
PoliticiansInstitutionsInsiders
PoliticianTransactionAmountTradedFiled
Donald Trump
Republican · Executive
Sale≥$50KJun 12Aug 22
Donald Trump
Republican · Executive
Purchase≥$100KMay 11Jul 1
Donald Trump
Republican · Executive
Purchase≥$1KMar 26May 13
Donald Trump
Republican · Executive
Purchase≥$1KMar 23May 13
Kevin Hern
Republican · House · OK-1
Sale≥$1KSep 2Sep 25

Congressional trading data provided by QuiverQuant

Product segmentsGeography
FY2025 · USD

How Colgate-Palmolive Company turned $20.4B of revenue into $3.3B of operating income.

Revenue
Oral, Personal and Home Care$15.8B▲ 0.97% YoY
Pet Nutrition$4.6B▲ 2.90% YoY
Total revenue$20.4B
Gross profit$12.3B60.1%
Operating income$3.3B16.2%